drugset / Trial / NCT00459641

Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts

NCT00459641 ↗

Phase 2 Withdrawn Kuros Biosurgery AG
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a randomised, controlled, open-label study of a single intralesional administration of I-040302 or a single bone marrow aspirate or a single steroid injection (methylprednisolone). Subjects will undergo screening with X-ray and magnetic resonance imaging (MRI) in the diagnosis of a solitary bone cyst.

Timeline

Start
2012-12
Primary completion
2014-06
Completion
2019-07

Outcome

Outcome not reported

Stopped (Enrollment): “Stopped before any site initiation or any recruitment due to change in overall product development plan”

Drugs

EvaluationDrugModalityDoseRoute
Subject I-040302 Unknown 1 mg Other
Subject I-040302 Unknown 2 mg Other
Subject I-040302 Unknown 4 mg Other

Indications